Neuroprotective potential of fasudil mesylate in brain ischemia-reperfusion injury of rats - PubMed (original) (raw)

Neuroprotective potential of fasudil mesylate in brain ischemia-reperfusion injury of rats

Qin Li et al. Cell Mol Neurobiol. 2009 Mar.

Abstract

We previously reported that inhibition of Rho-kinase (ROCK) by hydroxyl fasudil improves cognitive deficit and neuronal damage in rats with chronic cerebral ischemia (Huang et al., Cell Mol Neurobiol 28:757-768, 2008). In this study, fasudil mesylate (FM) was investigated for its neuroprotective potential in rats with ischemia following middle cerebral artery occlusion (MCAO) and reperfusion. The effect of fasudil mesylate was also studied in rat brain cortical and hippocampal slices treated with oxygen-glucose deprivation (OGD) injury. Gross anatomy showed that cerebral infarct size, measured with 2,3,5-triphenyltetrazolium chloride (TTC) staining, was significantly smaller in the FM-treated than in the non-FM-treated ischemic rats. In the brain regions vulnerable to ischemia of ischemic rats, fasudil mesylate was also found to significantly restore the enzyme protein expression level of endothelial nitric oxide synthase (eNOS), which was decreased in ischemia. However, it remarkably reduced the protein synthesis of inducible nitric oxide synthase (iNOS) that was induced by ischemia and reperfusion. In rat brain slices treated with OGD injury, fasudil mesylate increased the neuronal cell viability by 40% for cortex and by 61% for hippocampus, respectively. Finally, in the presence of OGD and fasudil mesylate, superoxide dismutase (SOD) activity was increased by 50% for cortex and by 58% for hippocampus, compared to OGD only group. In conclusion, our in vivo study showed that fasudil mesylate not only decreased neurological deficit but also reduced cerebral infarct size, possibly and at least partially by augmenting eNOS protein expression and inhibiting iNOS protein expression after ischemia-reperfusion.

PubMed Disclaimer

References

    1. J Neurosci Methods. 1990 Jan;31(1):43-6 - PubMed
    1. Nature. 2000 Sep 28;407(6803):538-41 - PubMed
    1. J Cereb Blood Flow Metab. 1990 Mar;10(2):290-3 - PubMed
    1. Neurochem Res. 1984 Jun;9(6):785-801 - PubMed
    1. Nat Med. 2002 May;8(5):473-9 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources